BusinessMYnd Analytics’ CEO presents at Defense Entrepreneurs Forum -- Silicon ValleyBy Nasdaq OMXNov 11, 2016, 5:30 PM UTC
BusinessBreakthrough Clinical Trial to be featured on CNN: Reductions in Suicidality, Depression, and Post-Traumatic StressBy Nasdaq OMXNov 11, 2016, 12:00 AM UTC
BusinessMYnd Analytics presents to the American Legion Committee on PTSD/TBIBy Nasdaq OMXOct 12, 2016, 9:00 AM UTC
BusinessMYnd Analytics, Inc. Announces Appointment of Thomas Tierney to Board of DirectorsBy Nasdaq OMXOct 4, 2016, 12:01 PM UTC
BusinessEarth Science Tech, Inc Announces Positive Results from First Pre-Clinical Study on New Hampshire Participate #1 of Dysfunctional Veterans with PTSD (Posttraumatic Stress Disorder) using ETST High Grade Hemp CBD (Cannabidiol)By Nasdaq OMXApr 11, 2016, 2:06 PM UTC
BusinessMYnd Analytics Receives IRB Approvals for SMART-MD Replication TrialBy Nasdaq OMXApr 1, 2016, 12:30 PM UTC
BusinessEarth Science Tech Announces Strategic Alliance with RRNP Healthcare and Dysfunctional Veterans of New Hampshire to conduct its First 30-Day PTSD Clinical Study with Veterans using ETST High Grade Hemp CBD (Cannabidiol) OilBy Nasdaq OMXMar 28, 2016, 12:00 PM UTC
BusinessMYnd Analytics Expands Its Business With Opening of First MYnd Analytics Center in Southern CaliforniaBy Nasdaq OMXMar 9, 2016, 12:00 PM UTC
